Renal impairment is prevalent in pediatric NAFLD/MASLD and associated with disease severity. Mouzaki, M; Yates, KP; Arce-Clachar, AC; Behling, C; Blondet, NM; Fishbein, MH; Flores, F; Adams, KH; Hertel, P; Jain, AK; Molleston, JP; Schwimmer, JB; Vos, MB; Xanthakos, SA. Journal of Pediatric Gastroenterology and Nutrition. 2024; 79:238-249.

Development of Fibro-PeN, a clinical prediction model for moderate-to-severe fibrosis in children with nonalcoholic fatty liver disease. Wang, A; Blackford, AL; Behling, C; Wilson, LA; Newton, KP; Xanthakos, SA; Fishbein, MH; Vos, MB; Mouzaki, M; Molleston, JP; Wagoner, A; Wilson, LA; Woreta, T; Yates, KP. Hepatology. 2024; 79:1381-1392.

Food Insecurity and Pediatric Nonalcoholic Fatty Liver Disease Severity. Orkin, S; Zhao, X; Setchell, KD R; Carr, E; Arce-Clachar, AC; Bramlage, K; Huang, R; Fei, L; Beck, AF; Fawaz, R; Valentino, PL; Xanthakos, SA; Mouzaki, M. The Journal of Pediatrics. 2024; 265:113818.

Nutrition assessment and MASH severity in children using the Healthy Eating Index. Jain, AK; Buchannan, P; Yates, KP; Belt, P; Schwimmer, JB; Rosenthal, P; Murray, KF; Molleston, JP; Scheimann, A; Xanthakos, SA; Boyett, S; Contos, MJ; Luketic, VA C; Sanyal, AJ. Hepatology Communications. 2023; 7.

Clinical Performance of Transient Elastography With Comparison to Quantitative Magnetic Resonance Imaging, Ultrasound, and Biopsy in Children and Adolescents With Known or Suspected Fatty Liver Disease. Alves, VP V; Trout, AT; Dewit, M; Mouzaki, M; Arce-Clachar, AC; Bramlage, KS; Dillman, JR; Xanthakos, SA. Childhood Obesity. 2023; 19:461-469.

Development and Implementation of a Multidisciplinary Clinic Focused on the Care of Adolescents with Youth-Onset Type 2 Diabetes. Schaaf, L; Ley, S; Riegler, A; Poetker, A; Xanthakos, S; Sizemore, J; Crimmins, N; Helmrath, M; Tracy, R; Arce-Clachar, AC; Crail, J; Morwessel, N; Frenck, K; Tariq, F; Shah, AS. Journal of Multidisciplinary Healthcare. 2023; 16:2799-2807.

Presence of Alpha 1 Antitrypsin Risk Variants is Not Associated With Histologic Severity of Pediatric NAFLD. Khan, M; Klepper, C; Orkin, S; Arce-Clachar, AC; Bramlage, K; Fei, L; Miethke, A; Kohli, R; Xanthakos, S; Mouzaki, M. Journal of Pediatric Gastroenterology and Nutrition. 2023; 77:166-170.

Infliximab Therapy for Pediatric Crohn Disease and Ulcerative Colitis. Colman, RJ; Dykes, DM H; Arce-Clachar, AC; Saeed, SA; Minar, P. Pediatric Inflammatory Bowel Disease. : Springer Nature; Springer Nature; 2023.

Histologic Severity of Nonalcoholic Fatty Liver Disease Associates with Reduced Bone Mineral Density in Children. Khan, S; Kalkwarf, HJ; Hornung, L; Siegel, R; Arce-Clachar, AC; Sheridan, R; Ippisch, HM; Xanthakos, SA. Digestive Diseases and Sciences. 2023; 68:644-655.

Clinically Meaningful Body Mass Index Change Impacts Pediatric Nonalcoholic Fatty Liver Disease. Khurana, T; Klepper, C; Fei, L; Sun, Q; Bramlage, K; Arce-Clachar, AC; Xanthakos, S; Mouzaki, M. The Journal of Pediatrics. 2022; 250:61-66.e1.